Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SRZN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
20 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 82 days ago
Red flags: 2
69 filers reported a long position in SRZN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| TCG Crossover Management, LLC | $38.2M | 1.5M | Unchanged |
| Boxer Capital Management, LLC | $27M | 1.1M | +44.3% |
| MILLENNIUM MANAGEMENT LLC | $17.7M | 683.1K | -6.6% |
| Point72 Asset Management, L.P. | $17.2M | 664.3K | New |
| Venrock Adviser, LLC | $16.4M | 632.9K | Unchanged |
| STEMPOINT CAPITAL LP | $13.8M | 602.8K | +14.7% |
| PERCEPTIVE ADVISORS LLC | $13.1M | 504K | +119.7% |
| Spruce Street Capital LP | $11.2M | 432K | Unchanged |
| BlackRock, Inc. | $10.2M | 394.9K | +1,317.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.2M | 392.6K | +132.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.